Liver preserved for three days before transplant still functioning a year on

Publicly released:
International
Photo by julien Tromeur on Unsplash
Photo by julien Tromeur on Unsplash

A patient who received a human liver donation after the liver was preserved for three days outside the body is still alive and healthy a year on, according to international researchers. The team used a machine that supplied the liver with a blood substitute at normal body temperature, instead of putting the liver on ice, in an attempt to preserve it for longer. They say the liver functioned normally once transplanted, and the patient recovered well and is still healthy a year later. The researchers say more long-term research is needed on more patients, but this is a promising step for increasing the time an organ can be held for a potential transplant.

Media release

From: Springer Nature

Medicine: Human liver preserved for three days successfully transplanted

A patient who received a human liver that was preserved for three days outside of the body using machine perfusion remains healthy after one year, according to a paper published in Nature Biotechnology. This technology may expand the number of livers available for transplantation whilst potentially allowing surgery to be scheduled days in advance, possibly saving lives.

There is an increasing gap between the demand for liver transplants and the small number that are available. However, as clinical practice is to store donor livers for no more than about 12 hours on ice before transplantation, the number of organs that can be matched to transplant recipients is limited.

Pierre-Alain Clavien and colleagues demonstrate the preservation of a human liver for three days outside of the body using a machine that performs a technique known as ‘ex situ normothermic perfusion’ — whereby the organ, while outside the body, is supplied with a blood substitute at normal body temperature. The liver was transplanted into a patient suffering from several serious liver conditions, including advanced cirrhosis and severe portal hypertension. The transplanted liver functioned normally, with minimal injury as blood flow from internal blood vessels returned, and only a basic immunosuppressant regime during the first six weeks after transplantation was needed. The patient rapidly recovered quality of life without any signs of liver damage, such as rejection or injury to the bile ducts. They remain healthy one year after surgery.

The authors caution that further research, with more patients and longer observation periods, is needed. However, these results suggest that such technology may not only increase the number of potential donor organs that are available, but also enhance the prospect of treating donor organs with drugs before transplantation.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Springer Nature, Web page The URL will go live after the embargo ends
Journal/
conference:
Nature Biotechnology
Research:Paper
Organisation/s: University Hospital Zurich, Switzerland
Funder: The project was performed and mostly funded under the roof of Wyss Zurich Translational Center, Zurich, Switzerland. Further financial supports were provided by the Helmut Horten, PROMEDICA and Liver and Gastrointestinal Disease Foundations.
Media Contact/s
Contact details are only visible to registered journalists.